ALDR - Alder Biopharmaceuticals, Inc.

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/2015
Total Revenue1,619113-
Cost of Revenue1,619113-
Gross Profit---
Operating Expenses
Research Development252,902132,76069,611
Selling General and Administrative38,10225,09816,718
Non Recurring---
Others---
Total Operating Expenses---
Operating Income or Loss-291,004-157,858-86,329
Income from Continuing Operations
Total Other Income/Expenses Net2,7681,789859
Earnings Before Interest and Taxes-288,236-156,069-85,470
Interest Expense---
Income Before Tax-288,236-156,069-85,470
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-288,879-156,254-85,470
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-288,879-156,254-85,470
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-288,879-156,254-85,470